Zheng Yu Yuan
Fundador en MicuRx Pharmaceuticals, Inc. .
Cargos activos de Zheng Yu Yuan
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
MicuRx Pharmaceuticals, Inc.
 MicuRx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology MicuRx Pharmaceuticals, Inc. is a holding company, which engages in the discovery, development, and commercialization of safe and effective antimicrobial therapeutics for multidrug-resistant superbag infections. The company was founded by Zheng Yu Yuan and Mikhail Fedorovich Gordeev in March 2007 and is headquartered in Pudong, China. | Director/Miembro de la Junta | 01/01/2008 | - |
| Director Ejecutivo | 17/07/2007 | - | |
| Fundador | 01/03/2007 | - | |
| Presidente | 17/07/2007 | - | |
Shanghai MicuRx Pharmaceutical Co., Ltd.
 Shanghai MicuRx Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Shanghai MicuRx Pharmaceutical Co., Ltd. engages in the experimenting, discovering, and development of innovative medicines. Its product pipelines focus on the treatment of resistant Gram-positive and Gram-negative bacterial infections. The company was founded by Zheng Yu Yuan and Mikhail F. Gordeev on August 7, 2012 and is headquartered in Shanghai, China. | Director Ejecutivo | 07/08/2012 | - |
| Presidente | 07/08/2012 | - | |
| Fundador | 07/08/2012 | - |
Historial de carrera de Zheng Yu Yuan
Antiguos cargos conocidos de Zheng Yu Yuan.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| GlaxoWellcome /Pharmocology Unit/ | Corporate Officer/Principal | - | - |
| Syntex Chemicals, Inc. | Corporate Officer/Principal | - | - |
| AFFYMAX, INC. | Corporate Officer/Principal | - | - |
Vicuron Pharmaceuticals LLC
 Vicuron Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Vicuron Pharmaceuticals LLC develops pharmaceutical products. It engages in discovering, developing, manufacturing, and commercializing vital medicine for seriously ill patients. The company offers anidulafungin drug, which prevents cell wall formation and other infectious fungi. It also offers antibiotic for the treatment of complicated skin and soft-tissue infections. The company was founded by Christopher T. Walsh in 1995 and is headquartered in King of Prussia, PA. | Fundador | - | - |
| Corporate Officer/Principal | - | - |
Formación de Zheng Yu Yuan.
| Cornell University | Doctorate Degree |
| Fudan University | Undergraduate Degree |
Estadísticas
Internacional
| Estados Unidos | 5 |
| China | 3 |
| Reino Unido | 2 |
Operativa
| Corporate Officer/Principal | 4 |
| Founder | 3 |
| Chief Executive Officer | 2 |
Sectorial
| Health Technology | 5 |
| Consumer Services | 3 |
| Commercial Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| AFFYMAX, INC. | Health Technology |
 | Health Technology |
| Empresas privadas | 4 |
|---|---|
Vicuron Pharmaceuticals LLC
Vicuron Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Vicuron Pharmaceuticals LLC develops pharmaceutical products. It engages in discovering, developing, manufacturing, and commercializing vital medicine for seriously ill patients. The company offers anidulafungin drug, which prevents cell wall formation and other infectious fungi. It also offers antibiotic for the treatment of complicated skin and soft-tissue infections. The company was founded by Christopher T. Walsh in 1995 and is headquartered in King of Prussia, PA. | Health Technology |
| GlaxoWellcome /Pharmocology Unit/ | Commercial Services |
MicuRx Pharmaceuticals, Inc.
MicuRx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology MicuRx Pharmaceuticals, Inc. is a holding company, which engages in the discovery, development, and commercialization of safe and effective antimicrobial therapeutics for multidrug-resistant superbag infections. The company was founded by Zheng Yu Yuan and Mikhail Fedorovich Gordeev in March 2007 and is headquartered in Pudong, China. | Health Technology |
| Syntex Chemicals, Inc. |
- Bolsa de valores
- Insiders
- Zheng Yu Yuan
- Experiencia
